(Global Executive Moves is a news service brought to you by Kingsley Gate Partners. This should not to be construed as placements made by KGP.)
Life Science Industry Banner - Advancing Healthcare Solutions
Mouse Scroll Icon
May 2021

Senti Biosciences Appoints Deborah Knobelman as Chief Financial Officer

Senti Biosciences announced Deborah Knobelman, was appointed Chief Financial Officer, effective May 19, 2021. Deborah brings over 20 years of experience most recently, serving in interim C-Suite roles for numerous life sciences companies and, before that, as CFO for Zeno Health (formerly GeneriCo) and CBO for Ampio Pharmaceuticals Inc.

Senti Biosciences is a team of engineers, scientists, and entrepreneurs on a mission to leverage synthetic biology to treat the most pressing diseases. It is privately held and based in San Francisco, CA.